Cargando…
Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power
BACKGROUND: Sample sizes for single-stage phase II clinical trials in the literature are often based on exact (binomial) tests with levels of significance (alpha (α) <5% and power >80%). This is because there is not always a sample size where α and power are exactly equal to 5% and 80%, respec...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504941/ https://www.ncbi.nlm.nih.gov/pubmed/23169334 http://dx.doi.org/10.1038/bjc.2012.444 |